
What We're Reading: Drug Price TV Ruling Upheld; WHO Ends Hydroxychloroquine Study; Caution Issued on Rally Attendance
A panel has ruled that pharmaceutical companies are not required to disclose drug prices in TV ads; the World Health Organization (WHO) halted its study of hydroxychloroquine to treat coronavirus disease 2019; Oklahoma officials warn medically vulnerable individuals to stay home from President Trump’s rally this weekend.
Panel Rules Drug Makers Do Not Have to Disclose Prices in TV Ads
A Washington, DC, panel blocked a rule forcing drug makers to display drug prices in television advertisements, Court House News
WHO Ends Hydroxychloroquine Testing in Patients With COVID-19
The World Health Organization (WHO) announced it would halt testing of the malaria drug hydroxychloroquine in the Solidarity Trial, a multicountry study investigating treatments for coronavirus disease 2019 (COVID-19), Reuters
Officials Issue Caution on Trump Rally Attendance
Officials in Tulsa, Oklahoma, are warning medically vulnerable populations (those over 60 or with compromised immune systems) to stay home from President Trump’s rally scheduled for Saturday, June 20, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.